These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26505327)

  • 21. Increase in echogenicity of echolucent carotid plaques after treatment with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled, randomized trial.
    Cesarone MR; Belcaro G; Nicolaides AN; Geroulakos G; Bucci M; Dugall M; De Sanctis MT; Incandela L; Griffin M; Sabetai M
    Angiology; 2001 Oct; 52 Suppl 2():S19-25. PubMed ID: 11666118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pycnogenol® supplementation in minimal cognitive dysfunction.
    Hosoi M; Belcaro G; Saggino A; Luzzi R; Dugall M; Feragalli B
    J Neurosurg Sci; 2018 Jun; 62(3):279-284. PubMed ID: 29754480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation.
    Belcaro G; Luzzi R; Hu S; Cesarone MR; Dugall M; Ippolito E; Corsi M; Caporale S
    Panminerva Med; 2014 Mar; 56(1):41-8. PubMed ID: 24637472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pycnogenol® supplementation to relieve symptoms after hemorrhoidectomy.
    Belcaro G; Cotellese R; Corsi M; Cesarone MR; Scipione C; Scipione V; Cornelli U; Ippolito E; Dugall M; Hosoi M; Feragalli B
    Minerva Surg; 2024 Jun; 79(3):309-314. PubMed ID: 38847768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19).
    Belcaro G; Cornelli U; Cesarone MR; Scipione C; Scipione V; Hu S; Feragalli B; Corsi M; Cox D; Cotellese R; Hosoi M; Burki C
    Minerva Med; 2022 Apr; 113(2):300-308. PubMed ID: 34060731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Femoral plaque echogenicity and cardiovascular risk in claudicants.
    Schiano V; Sirico G; Giugliano G; Laurenzano E; Brevetti L; Perrino C; Brevetti G; Esposito G
    JACC Cardiovasc Imaging; 2012 Apr; 5(4):348-57. PubMed ID: 22498323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon.
    Vinciguerra G; Belcaro G; Bonanni E; Cesarone MR; Rotondi V; Ledda A; Hosoi M; Dugall M; Cacchio M; Cornelli U
    J Sports Med Phys Fitness; 2013 Dec; 53(6):644-54. PubMed ID: 24247188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study.
    Errichi BM; Belcaro G; Hosoi M; Cesarone MR; Dugall M; Feragalli B; Bavera P; Hosoi M; Zulli C; Corsi M; Ledda A; Luzzi R; Ricci A
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):21-7. PubMed ID: 22108473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [High-resolution ultrasonographic study of atherosclerotic lesions of the carotid arteries in borderline essential arterial hypertension].
    Pellegrino L; Prencipe G
    G Ital Cardiol; 1994 Oct; 24(10):1199-210. PubMed ID: 7835550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Echogenic carotid plaques are associated with aortic arterial stiffness in subjects with subclinical carotid atherosclerosis.
    Zureik M; Bureau JM; Temmar M; Adamopoulos C; Courbon D; Bean K; Touboul PJ; Benetos A; Ducimetière P
    Hypertension; 2003 Mar; 41(3):519-27. PubMed ID: 12623953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-stenotic echolucent ultrasound-assessed femoral artery plaques are predictive for future cardiovascular events in middle-aged men.
    Schmidt C; Fagerberg B; Hulthe J
    Atherosclerosis; 2005 Jul; 181(1):125-30. PubMed ID: 15939063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®.
    Hu S; Hosoi M; Belcaro G; Dugall M; Feragalli B; Cotellese R; Luzzi R
    Minerva Cardioangiol; 2019 Oct; 67(5):392-398. PubMed ID: 31637898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duplex study of the carotid and femoral arteries of patients with rheumatoid arthritis: a controlled study.
    Abu-Shakra M; Polychuck I; Szendro G; Bolotin A; Jonathan BS; Flusser D; Buskila D; Sukenik S
    Semin Arthritis Rheum; 2005 Aug; 35(1):18-23. PubMed ID: 16084220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification by ultrasound evaluation of the carotid and femoral arteries of high-risk subjects missed by three validated cardiovascular disease risk algorithms.
    Postley JE; Luo Y; Wong ND; Gardin JM
    Am J Cardiol; 2015 Nov; 116(10):1617-23. PubMed ID: 26434511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pycnogenol® improvements in asthma management.
    Belcaro G; Luzzi R; Cesinaro Di Rocco P; Cesarone MR; Dugall M; Feragalli B; Errichi BM; Ippolito E; Grossi MG; Hosoi M; Errichi S; Cornelli U; Ledda A; Gizzi G
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):57-64. PubMed ID: 22108478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study.
    López-Melgar B; Fernández-Friera L; Oliva B; García-Ruiz JM; Peñalvo JL; Gómez-Talavera S; Sánchez-González J; Mendiguren JM; Ibáñez B; Fernández-Ortiz A; Sanz J; Fuster V
    J Am Coll Cardiol; 2017 Jul; 70(3):301-313. PubMed ID: 28705310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromsø study.
    Johnsen SH; Mathiesen EB; Fosse E; Joakimsen O; Stensland-Bugge E; Njølstad I; Arnesen E
    Circulation; 2005 Jul; 112(4):498-504. PubMed ID: 16027250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol®.
    Luzzi R; Belcaro G; Hosoi M; Feragalli B; Cornelli U; Dugall M; Ledda A
    Minerva Ginecol; 2017 Feb; 69(1):29-34. PubMed ID: 28116886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echolucent or predominantly echolucent femoral plaques predict early restenosis after eversion carotid endarterectomy.
    Dósa E; Hirschberg K; Apor A; Járányi Z; Entz L; Acsády G; Hüttl K
    J Vasc Surg; 2010 Feb; 51(2):345-50. PubMed ID: 20141957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carotid artery atherosclerotic profile as a predictor of the aorta atherosclerotic profile in patients with cerebrovascular events.
    Hueb JC; Bazan R; Pereira Braga G; Fusco DR; Zanati Bazan SG; Bojikian Matsubara B
    Cerebrovasc Dis; 2013; 36(1):26-32. PubMed ID: 23920380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.